drugset / Trial / NCT00358579
Comparing Vasopressin and Adrenaline in Patients With Cardiac Arrest
Phase 3
Completed
727 enrolled
Singapore General Hospital
Alexandra Hospital · collabChangi General Hospital · collabNational Medical Research Council (NMRC), Singapore · collabNational University Hospital, Singapore · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The effectiveness of medications in cardiac arrest has been greatly debated and questioned. Historically intravenous adrenaline has been the drug of choice since 1906. There have been few formal evaluations to determine the value of adrenaline for cardiac arrest, and clinical trials have not been able to show any benefit with intravenous adrenaline (compared to placebo or no treatment) in the field. Thus the purpose of this study is to compare vasopressin and adrenaline in the treatment of cardiac arrest to answer the question whether there is an improvement in survival between vasopressin and adrenaline.
Timeline
- Start
- 2006-03
- Primary completion
- 2009-01
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Epinephrine | Other / unclassified | 1 mg | Intravenous |
| Comparator | Vasopressin | Peptide | 40 iu | Intravenous |